A Study to Assess Efficacy and Safety of Adimanebart in Adult and Pediatric Participants With DOK7-,MUSK-, AGRN-, or LRP4- Congenital Myasthenic Syndromes (CMS)
Clinical trial NCT07746089 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07746089
- Sponsor
- argenx
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2026-09-01
- Primary completion
- 2030-10-01
- Enrollment
- 105
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.